Podiatry Revenue Diagnostic in Short:
The pattern: podiatry practices lose revenue while the schedule is full, claims are going out, and the EHR is running fine. The leak is rarely one thing.
The data: CMS’s 2024 CERT data puts podiatry’s improper payment rate at 11.2 percent ($216.9 million projected), and lower limb orthoses specifically at 35.2 percent ($91.2 million). Two 2025 OIG audits found 44 of 100 modifier 25 claims and 49 of 100 routine foot care claims noncompliant.
The cause: insufficient documentation alone accounts for 76.4 percent of podiatry’s improper payments. This is a paperwork and process gap, not a volume problem.
The fix: a structured, 13-point diagnostic across your internal team, RCM vendor, EHR, coding, denials, AR, and payer contracts, before deciding whether to switch vendors.
Table of Contents
Revenue is falling. But who, or what, is responsible?
Your RCM vendor may be part of the problem. It may also be one part of a larger problem, or no part of it at all. Here’s how to find out before you sign with someone new.
Patient volume is stable. The schedule is full of nail debridements, wound care visits, orthotic fittings, and surgical cases. The RCM vendor is submitting claims. The billing team says it’s working the AR. The EHR is functioning.
Revenue is still declining.
For most podiatry practices, the first reaction is the same: the billing company isn’t performing, so it’s time to find a new one. Sometimes that’s the right call. Often it isn’t. This diagnostic is written for podiatry practices doing $5 million or more in annual revenue, multi-provider, multi-location groups running routine foot care, wound care, DME and orthotics, and surgical service lines side by side.
What the Data Actually Shows
Podiatry carries one of the higher improper payment rates in Medicare outpatient care. According to CMS’s 2024 Medicare Fee-for-Service Supplemental Improper Payment Data, podiatry claims carried an 11.2 percent improper payment rate in the 2024 reporting period, projected at $216.9 million. Insufficient documentation accounted for 76.4 percent of those errors, with incorrect coding responsible for another 11.5 percent.
- Insufficient documentation – 76.4%
- Incorrect coding – 11.5%
- No documentation – 7.2%
- Medical necessity – 4.4%
- Other – 0.6%
Two Office of Inspector General audits, both issued in 2025 against 2019 and 2020 claims data, add detail to that pattern. One found that 44 of 100 sampled podiatry evaluation and management claims billed with modifier 25 did not comply with Medicare requirements, projecting $39.6 million in improper payments out of $222.5 million reviewed. A related audit of routine foot care claims found 49 of 100 sampled claims noncompliant, projecting roughly $4.4 million in improper payments. Orthotics and lower limb orthoses carry even higher risk: CMS’s 2024 improper payment data puts that category’s rate at 35.2 percent, projected at $91.2 million.
The American Podiatric Medical Association has pushed back on how those OIG findings get used, pointing out that the reviewed claims date to 2019 and 2020 and that extrapolated estimates can overstate the scale of a current problem. Whatever weight you give that pushback, the underlying pattern holds. A small number of podiatry-specific rules, documentation for routine foot care, modifier 25 use, and coding accuracy, account for most of what auditors and payers find wrong.
Key Takeaways
Coding & Documentation
- Documentation drives the losses, not clinical judgment. 76.4 percent of podiatry’s improper payments trace to insufficient documentation, not incorrect treatment decisions.
- Q-modifiers are the single largest podiatry-specific leak. Miss the class finding documentation behind Q7, Q8, or Q9, and the claim denies as a statutory exclusion regardless of how correctly everything else was coded.
- NCCI bundling errors are preventable at the source. Selective (97597) and excisional (11042) debridement codes are mutually exclusive for the same wound, same date, a rule a pre-submission scrub catches every time.
Reimbursement & AR
- Orthotics carry disproportionate risk. Lower limb orthoses have a 35.2 percent improper payment rate, roughly three times podiatry’s overall rate.
- Medicare code parity doesn’t guarantee commercial parity. CMS priced the new off-the-shelf codes L1933 and L1952 equal to their custom-fit equivalents; nothing requires commercial payers to follow.
- Total AR hides the real number. What matters is recoverable AR by payer, service line, and denial reason, not one blended balance.
The 13 Diagnostic Checkpoints
By the time your RCM vendor touches anything, a claim has already passed through scheduling, eligibility, prior authorization, the encounter, documentation, coding, and charge capture. The vendor controls some of these steps. Your staff controls others. The EHR shapes nearly all of them, and the payer controls a piece none of you control at all. Instead of asking whether the vendor is bad, work through which link in the chain is actually underperforming.
1. Is Your In-House Revenue Cycle Team Underperforming?
Before looking at the vendor, look at the people inside the practice. Podiatry billing draws on knowledge that general medical billers often don’t have: Q-modifier logic, class finding documentation, HCPCS L-codes for orthotics, and NCCI edits specific to wound debridement and nail procedures.
What to measure: claims per FTE, AR accounts worked per FTE, denials resolved per FTE, charges entered within 24 hours, routine foot care claims with a Q-modifier attached before submission, DME claims with same-and-similar documentation on file, and charge lag from date of service to claim submission.
Ask Yourself
- Do we know our claims-per-FTE and AR-worked-per-FTE numbers, or are we estimating?
- Are role-specific challenges (front desk, coders, DME staff, AR follow-up) measured separately, or lumped into one general “billing team” number?
- Does our coding staff have podiatry-specific expertise, or general medical coding knowledge applied to a podiatry practice?
- Is patient billing handled with the same rigor as claims billing, or treated as an afterthought?
- What does our reporting actually diagnose: root causes by service line, or just activity counts?
- Where could AI inclusion reduce manual load on this team today?
- Are we following industry benchmarks for podiatry staffing ratios, or just doing what we’ve always done?
2. Is Your Existing RCM Vendor Actually Underperforming?
Now look at the vendor, but with evidence, not impressions. The wrong question is how many claims the vendor worked. The right ones are what got collected, what got denied and why, how much AR was actually recovered versus just touched, and what share of denials were preventable. Activity reporting isn’t outcome reporting.
Build a vendor performance scorecard around net collection rate, clean claim rate by service line, denial rate, AR over 90 days, days in AR, first-pass resolution rate, and DME and orthotics recovery rate specifically.
Ask Yourself
- Does our vendor’s reporting actually diagnose why revenue moved by service line, or just show that it did?
- Can our vendor break down performance by payer, provider, and location?
- Do they understand podiatry-specific billing challenges, or are we one of many specialty types they handle the same way?
- What’s their integration capability with our EHR and practice management system?
- Are they applying industry best practices we can name and measure?
- Where is AI inclusion already part of their process, versus something still done by hand?
- If we handed a competitor our claims and AR data today, would their scorecard look meaningfully different
See What a Podiatry-Specific Billing Team Actually Catches
BillingParadise’s podiatry medical billing team works CMS-1500 and UB04 claims with coders who understand Q-modifiers, class findings, and NCCI edits by default, not as a specialty they occasionally handle.
3. Is Your EHR Creating Revenue Friction?
The EHR itself is rarely the problem. How it’s configured for podiatry’s specific billing rules, and how your team actually uses it day to day, usually is. Worth checking: whether Q7, Q8, and Q9 logic is built into your templates, whether L-code selection is configured correctly, and whether your system flags NCCI conflicts before a claim goes out.
Then look for the workarounds people have quietly built around the system: spreadsheets tracking authorization numbers, manual trackers for the six-month physician visit requirement. Every one of those is a sign the EHR isn’t doing something it should be doing natively.
Ask Yourself
- Does our EHR’s integration capability actually connect to our clearinghouse and DME MAC before submission?
- How many spreadsheets exist because the EHR’s native reporting doesn’t diagnose what our team needs to see?
- Is our fee schedule and modifier configuration built for podiatry specifically, or inherited from a generic template?
- Where does AI inclusion already exist in our EHR, and are we actually using it?
- Are a coder’s, provider’s, and DME specialist’s views all reflected in how the system is set up?
- Does our patient billing workflow follow best practices for ABN and DME documentation?
- If we audited our EHR configuration today, would we find more configuration problems or workflow problems?
Get Your Podiatry EHR Configuration Reviewed
BillingParadise supports podiatry-specific fee schedules, Q-modifier templates, and NCCI flagging inside more than 30 EHR and practice management systems.
4. Are Eligibility and Authorization Failures Creating Avoidable Revenue Loss?
A perfectly coded claim still fails if authorization wasn’t secured, or wasn’t documented correctly. Podiatry has more prior authorization touchpoints than many specialties realize: podiatric surgery, advanced imaging, custom orthotics (L3000 to L3030), and certain ankle-foot orthoses.
CPT code L1951, for a prefabricated ankle-foot orthosis, has required prior authorization since August 12, 2024, when CMS expanded its DMEPOS prior authorization program to include it. A second, separate requirement layered on top starting December 1, 2024: L1951 claims must show a published PDAC coding verification, or the line denies as incorrect coding regardless of authorization status.
Ask Yourself
- Do we have a documented authorization number, not just a verbal approval, on file before every qualifying claim?
- Where could automated same-and-similar checks replace a manual DME eligibility process?
- Does our reporting diagnose which service lines generate the most authorization-related denials?
- Is ABN accuracy confirmed before the visit, or discovered afterward as a billing surprise?
- Are front-desk staff kept current on authorization requirements that changed as recently as 2024?
- Does our authorization process reflect industry best practices, or is it whatever the front desk has always done?
- What’s the integration between our scheduling system and authorization tracking?
Fix Authorization Gaps Before They Become Denials
BillingParadise’s podiatry patient eligibility team verifies authorization status, same-and-similar DME checks, and secondary payer coverage before the visit, not after the claim comes back.
5. Is Your Q-Modifier and Class Finding Documentation Supporting the Claims You’re Submitting?
This is the single largest, most podiatry-specific source of revenue leakage in the specialty. Medicare excludes routine foot care by statute unless a qualifying systemic condition and a documented class finding are present. Q7 requires one Class A finding, Q8 requires two Class B findings, and Q9 requires one Class B finding plus two Class C findings. Miss the modifier or the documentation, and the claim denies as a statutory exclusion regardless of how correctly everything else was coded.
Ask Yourself
- Is a Q-modifier and its class finding documented in the same visit note, or added after the fact?
- Where could automated flags catch a missing Q-modifier before submission?
- Does our reporting diagnose what percentage of routine foot care claims go out correct the first time?
- Are class finding documentation habits supported by templates, or left to memory?
- Do we track the six-month physician visit requirement, or find out it’s missing only after a denial?
- Are we documenting medical necessity when routine foot care frequency limits are exceeded?
- If we pulled our last 50 routine foot care claims, how many would have complete documentation on first submission?
Audit Your Last 50 Routine Foot Care Claims
This is the single largest podiatry-specific leak in the specialty. BillingParadise’s podiatry coding team can run a Q-modifier and class finding compliance check against a recent claim sample at no cost.
6. Are Wound Care and NCCI Bundling Errors Creating Revenue Leakage?
Wound debridement billing depends on depth, tissue type, and correct code selection. Selective debridement (97597) and excisional debridement (11042 and related codes) are mutually exclusive for the same wound on the same date. Multiple wounds at different depths need the deepest wound billed as the base code, with shallower wounds appended with modifier 59 or XS.
Ask Yourself
- Does our documentation specify wound depth and tissue type clearly enough to support the code billed?
- Where could pre-submission NCCI edit checks catch a bundling conflict before the claim goes out?
- Are coders supported with ongoing training on which code families are mutually exclusive?
- Does our reporting diagnose wound care denials separately from routine foot care denials?
- Is patient billing calculated correctly when modifiers 59 or XS apply to secondary wounds?
- Are we auditing a sample of wound care claims against documentation regularly?
- How much of our denied wound care revenue traces to a bundling conflict a scrub tool would have caught?
Catch Bundling Conflicts Before Submission
BillingParadise’s podiatry claims scrubbing checks wound debridement depth, tissue type, and NCCI code pairs against your documentation before a claim goes out, not after it denies.
7. Are You Capturing Revenue Across Every Service Line You Actually Run?
A podiatry practice bills across several distinct service lines at once: routine and at-risk foot care, wound care, DME and orthotics, and surgery. It’s common for charges from one line, especially DME dispensed at the point of care, to lag behind or fall out of the workflow entirely.
Ask Yourself
- Do we reconcile DME and orthotics dispensed against DME claims billed on a regular schedule?
- Where does automated charge capture already close this gap, and where are we still relying on manual entry?
- Does our reporting diagnose charge lag separately by service line?
- Is a surgical coder’s workload versus a DME specialist’s workload creating a bottleneck?
- Do we track the downstream effect of late DME charge entry on patient balances?
- Does dispensing automatically generate a charge, or is that still a manual step?
- Do we know our charge-lag benchmarks by service line?
8. Are Preventable Claim Errors Creating Revenue Leakage?
Beyond Q-modifiers and NCCI bundling, podiatry claims fail for reasons specific to the specialty’s modifier logic: a missing toe modifier (TA, T5, T1 through T9), missing laterality (RT or LT), or a same-day E/M billed without modifier 25. Medicare allows claims within one calendar year; most commercial payers require 90 to 180 days, and a missed window is a non-appealable denial.
Ask Yourself
- Do we have a pre-submission scrubbing step that catches toe modifiers and laterality specifically?
- Where could automated scrubbing against podiatry-specific modifier rules reduce preventable errors?
- Does our reporting diagnose which error types recur most?
- Are coders juggling multiple coding types simultaneously a factor in how many errors slip through?
- Is our clearinghouse catching timely filing risk before the deadline, or only after?
- Do we know our clean claim rate against industry benchmarks?
- How much of our denied revenue traces to errors that happened before the claim reached our RCM vendor?
9. Are You Managing Denials, or Learning From Them?
With podiatry’s improper payment and denial patterns running above general Medicare benchmarks, the more useful question isn’t how many denials you’re getting. It’s why, and whether the same root cause keeps recurring. Sort every denial into preventable, correctable, appealable, recoverable, or non-recoverable, then build a root-cause matrix across payer, provider, service line, and dollar value.
Ask Yourself
- Does our reporting diagnose the root cause of each denial by service line?
- Where could denial pattern detection catch recurring issues before they repeat?
- Is our denial-management team staffed and measured appropriately across denial types?
- Do we know our preventable denial percentage, and is it improving?
- Are we applying best practices for denial categorization, or is “denied” the only status we track?
- Do resolved denials feed back into documentation templates?
- If the same denial reason showed up on 100 claims this quarter, would we know why?
Root-Cause Your Denials Instead of Just Working the Queue
BillingParadise’s podiatry denial management team sorts denials into preventable, correctable, appealable, recoverable, and non-recoverable, then builds the root-cause matrix by payer, provider, and service line.
10. Is Your AR Aging Without a Recovery Strategy?
Total AR is a number. It doesn’t tell you how much is actually collectible, and DME and orthotics claims tend to age longer than routine care claims because of the additional documentation payers request. Segment AR by age: 0 to 30 days for prevention, 31 to 60 for intensified follow-up, 61 to 90 for escalation, 91 to 120 as high priority, and 120-plus for recovery, appeal, escalation, or write-off.
Ask Yourself
- Does our reporting diagnose recoverable AR versus total AR?
- Where could automated aging alerts help prioritize which accounts to work first?
- Is patient billing AR tracked separately from insurance AR?
- Are DME appeals, which require different documentation than routine care appeals, reflected in how work is assigned?
- Do we know our days-in-AR number against industry benchmarks?
- Does aging data update in real time, or only after a manual export?
- If we wrote off every DME account over 120 days today, would we know how much was preventable?
Know Which Dollars in Your AR Are Actually Recoverable
BillingParadise’s podiatry AR team segments your aged accounts by payer, service line, and denial reason, combining AI-enabled analysis with insurance and patient follow-up to show what’s realistically collectible versus what’s a write-off waiting to happen.
11. Are Payers Reimbursing You What You Should Be Receiving?
Revenue can decline even with stable volume, submitted claims, and a manageable denial rate, because the shortfall is coming from reimbursement itself. Underpayments, outdated fee schedules, and inconsistent commercial payer policies on orthotics and DME can all quietly erode revenue without ever showing up as a denial.
Ask Yourself
- Does our reporting diagnose underpayment by payer and service line?
- Where could automated expected-versus-actual matching catch underpayments at the line-item level?
- Is contract negotiation staffed by someone who understands podiatry-specific rate structures?
- Are we auditing reimbursement, or reviewing contracts only at renewal?
- Does our payer mix reporting break out Medicare, Medicaid, and commercial rates clearly?
- Are expected rates loaded into our billing system, or is variance caught manually?
- Would we catch a 5 percent reimbursement drop on our top five codes before the next contract cycle?
12. Are Your Podiatry Codes Creating Reimbursement and Contract Variance?
Podiatry runs on a small, recognizable set of code families, and each one carries a different reimbursement risk profile. Treating them as one blended “denials and collections” number hides where the actual variance sits.
| Code Family | Examples | Primary Reimbursement Risk |
|---|---|---|
| Routine foot care | 11055–11057, 11719–11721 with Q7, Q8, Q9 | Statutory exclusion denial when class finding documentation is missing |
| Wound debridement | 97597, 11042–11047 | NCCI bundling denial when depth or tissue type is unclear |
| Orthotics and DME | L3000–L3030, L1932, L1933, L1951, L1952 | Coding verification and prior authorization gaps; higher improper payment rate |
| Evaluation and management | 99202–99215 with modifier 25 | Same-day E/M and procedure billed without separately identifiable documentation |
| Surgical | Modifiers 58, 59, 78, 79; laterality (RT, LT, TA, T1–T9) | Missing modifier zeroes out or bundles the payment |
Orthotics and lower limb orthoses carry some of the highest reimbursement risk in podiatry’s code set, at a 35.2 percent improper payment rate, nearly triple podiatry’s overall rate. CMS also created off-the-shelf parallel codes L1933 and L1952 for the custom-fit codes L1932 and L1951, effective for orthoses delivered on or after April 1, 2025, with Medicare fee schedules set equal to the custom-fit equivalents. Medicare parity does not guarantee commercial parity. If your top commercial payers haven’t updated their fee schedules to reflect the newer codes, that gap shows up as a lower per-unit reimbursement on a claim that paid without incident, exactly the kind of variance a denial report will never surface.
Ask Yourself
- Do we track reimbursement variance separately for each orthotics and DME code, or as one blended number?
- Where could automated CPT and HCPCS-level matching catch a code-specific underpayment before it compounds?
- Are our commercial payer contracts updated for the newer off-the-shelf parallel codes?
- Does our reporting diagnose lower limb orthoses variance separately, given its materially higher improper payment rate?
- Is a contract negotiator’s grasp of podiatry-specific HCPCS structures factored into who owns payer renewals?
- Are we following coding verification requirements, such as the PDAC review now required on L1951?
- If we ran an expected-versus-actual analysis on our top five orthotics and DME codes today, would the gap be worth renegotiating?
13. Do You Have a Revenue Intelligence Problem?
This is where everything above comes together. Most practices already have EHR data, billing data, claims, payments, denials, AR, and authorization data. What they usually don’t have is those pieces connected to each other, or broken out clearly by service line.
Traditional reporting tells you your AR is $1.8 million. Revenue intelligence tells you that AR grew by $210,000 because DME claims at one location moved into the 90-to-120-day bucket, and that $65,000 of that increase came from missing same-and-similar documentation specifically. The second version is something you can actually act on.
Ask Yourself
- Is our reporting built to diagnose why a number moved, or only to show that it moved?
- Where is AI already helping connect EHR, billing, claims, and payer data into one picture?
- Can we pull scheduling, authorization, billing, and payer data into a single source of truth?
- Is our data structured for a practice with multiple locations, service lines, and providers?
- Are we relying on revenue cycle analytics, or still on static monthly reports?
- Does our patient billing data connect to claims and reimbursement data, or live in a separate silo?
- If leadership asked why AR moved $200,000 last quarter, could we answer in a meeting?
The Decision Framework: Fix, Augment, or Replace
Once the assessment is done, every problem should land in one of five ownership categories, each with its own path forward.
- Internal team: optimize, train, measure, augment, restructure.
- RCM vendor: measure, remediate, monitor, rebid, transition.
- EHR or workflow: audit, reconfigure, train, automate, monitor.
- Payer reimbursement: analyze, validate, appeal, review the contract, escalate.
- Revenue visibility: connect the data, analyze it, quantify the gap, prioritize, monitor.
Not every revenue problem requires a new RCM vendor. Not every RCM vendor deserves to keep the business. The diagnosis has to come first.
A Podiatry Revenue Leakage Score
Score each of the following areas as low, medium, or high risk: in-house productivity, podiatry-specific coding expertise, RCM vendor performance, vendor visibility, EHR configuration, workflow efficiency, eligibility and authorization, Q-modifier and class finding documentation, wound care coding accuracy, DME and orthotics billing, code-level reimbursement and contract variance, claim quality, denials, AR aging, and revenue reporting. Weight and total the scores into a single number from 0 to 100.
| Score Range | What It Means |
|---|---|
| 0 to 20 | The revenue cycle is well controlled. |
| 21 to 40 | Worth watching. |
| 41 to 60 | At risk. |
| 61 to 80 | Significant leakage. |
| 81 to 100 | Critical. |
The point of the score isn’t another dashboard sitting unused. It’s a prioritized list of what to fix first.
Ten Questions to Answer Before Changing Your RCM Vendor
- Are our internal billing resources actually productive?
- Are we staffed appropriately for current volume across all our service lines?
- Is our existing RCM vendor producing measurable financial outcomes?
- Can we see vendor performance broken out by payer, provider, and service line?
- Is our EHR configured correctly for podiatry-specific coding and modifier rules?
- How many encounters are falling out before they ever become a claim?
- What are our five largest preventable denial categories?
- How much of our AR is realistically collectible, not just outstanding?
- Are our payers reimbursing us at the rates we agreed to, especially on DME and orthotics?
- Can we quantify, in dollars, exactly where revenue is leaking, code by code?
If you can’t answer most of these, you’re not ready to make a vendor decision. You’re guessing at one.
Already Have an RCM Vendor? Start There
Having a vendor already doesn’t mean the answer is automatically to replace them. Your current setup is the best place to start looking, because your vendor already holds your claims history, denial history, AR, payer data, and workflows going back months or years. A structured assessment should point to one of five outcomes: optimize, augment, reconfigure, hold accountable with real SLAs, or replace, but only once the evidence shows the current setup genuinely can’t deliver.
The Bottom Line
Podiatry practices don’t usually lose revenue because they’re not seeing enough patients. They lose it while the schedule is full, claims are going out, the vendor is producing reports, and the EHR is running fine. It leaks anyway, through a routine foot care claim missing a Q-modifier, a wound debridement code paired incorrectly, a DME claim missing same-and-similar documentation, a denial nobody root-caused, an AR account that aged past recovery.
The goal isn’t to bill more aggressively. It’s to know what you should have earned, what you actually earned, where the gap is, why it’s there, who owns it, and what has to change to close it.
